Antitumor effects of rhodium (II) complexes on mice bearing Ehrlich tumors
Braz. j. med. biol. res
;
27(1): 91-4, jan. 1994. tab
Artículo
en Inglés
| LILACS
| ID: lil-136497
ABSTRACT
Rhodium (II) trifluoracetate (TFARh), rhodium (II) trifluoracetate adduct with sulfadiazine (TFARh.Sd) and rhodium (II) acetate adduct with sulfisoxazole (RhSx) were tested in mice for acute toxicity, antitumoral activity against Ehrlich ascites carcinoma and for viability of Ehrlich tumor cells in culture. At ip doses up to 60 µmg/kg (40-70 and 59 mg/kg, respectively), these coumpounds had no toxic effects up to 14 days. At ip doses of 10 µmol Kg-1 day-1 for 5 days, TFARh and TFARh.Sd significantly increased the survival rate of mice bearing Ehrlich ascites cells (probability of survival to the end of 34th day, controls = 0.23, TFARh = 0.85, TFARh.Sd = 0.74). No significant effect was observed for RhSx. In vitro, these rhodium complexes at 40 µM significantly increased the number of dead cells in cultured Ehrlich tumor cells
Buscar en Google
Índice:
LILACS (Américas)
Asunto principal:
Rodio
/
Técnicas In Vitro
/
Carcinoma de Ehrlich
/
Protocolos de Quimioterapia Combinada Antineoplásica
Límite:
Animales
Idioma:
Inglés
Revista:
Braz. j. med. biol. res
Asunto de la revista:
Biologia
/
Medicina
Año:
1994
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS